Chat with us, powered by LiveChat

NEWSWISE FAST PITCH

Weekly events giving members the opportunity to meet with journalists online and pitch their story ideas.

“I haven’t enjoyed getting a pitch this much in, well…ever!” — Ben Gruber, Reuters

EVENT REGISTRATION

Cordant Health Solutions Live Professional Briefing

Introducing CORE™, Cordant's Comprehensive Oral fluid Rx Evaluation
The first drug monitoring solution to correlate drug concentrations in oral fluid with drug levels in blood plasma. Offering individualized drug testing for pain management.

Saturday, Mar 11, 2017, 11:00am - 12:00pm EST

EVENT DESCRIPTION

You are Invited to a Live Professional Briefing
Join us March 21 as Richard Stripp, Ph.D., Chief Scientific Officer at Cordant Health Solutions, explains how a new testing technology gives clinicians the insight of steady-state blood testing while also offering the ease and benefits of oral fluid testing to help clinicians assess medication levels for their chronic
pain patients.


Introducing CORE™, Cordant's Comprehensive Oral fluid Rx Evaluation
The first drug monitoring solution to correlate drug concentrations in oral fluid with drug levels in blood plasma. Offering individualized drug testing for pain management.

Testimony From a Current Family Medicine Physician Who Uses CORE in His Practice.
"Dose-correlation testing helps doctors detect problems on how patients are taking or not taking their meds," said Kwesi Grant-Acquah, M.D., a family physician at Omni Family Medical in Milwaukee. "If a patient's drug level is above or below the expected steady-state range at the prescribed dosage, the patient may not be taking the drug as directed or may have genetic or metabolic abnormalities that could require a therapy change."

According to Dr. Grant-Acquah, results from the CORE test provide physicians with actionable information to use in conversations with patients about how and when they are taking their medications. "Urine testing can't determine if a patient is adhering to exact dosing. All the physician knows is the patient took the drug before urine collection and not if proper dosing is being followed."

About the Speaker
As Cordant's Chief Scientific and Technical Officer, Dr. Stripp provides leadership to five toxicology laboratories across the country. He currently serves as a professor of forensic and clinical toxicology at the City University of New York. Additionally, Dr. Stripp is a member of various toxicology organizations, including the American Academy of Clinical Toxicology, and is a certified forensic consultant for the American Board of Forensic Examiners.

Dr. Stripp earned his Ph.D., in pharmacology and toxicology from the St. John's University College of Pharmacy and Allied Health Professions.


Registration is closed for this event.

For more information or questions, please email:

info@newswise.com

Join Newswise!

Newswise gives journalists access to the latest news and provides a platform for universities, institutions, and
journalists to spread breaking news to their audience.